drugset
drugset / Trial / NCT03489837

Phase III Study to Evaluate the Efficacy and Safety of HOB-048 CR Tab. in Comparison With HOB-048 Syrup in Patients With Cough Due to Acute or Chronic Bronchitis

NCT03489837 ↗

Phase 3 Completed 272 enrolled Hyundai Pharm
RandomizedParallel-groupSingle-blindTreatment

Summary

A randomized, double-blind, multicenter, active-controlled phase III study to evaluate the efficacy and safety of Levotuss CR tab. in comparison with Levotuss syrup in patients with cough due to acute or chronic bronchitis

Timeline

Start
2017-01
Primary completion
2018-10
Completion
2018-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levodropropizine Small molecule — Oral

Indications

No indication recorded.